AbbVie’s Options Trade
-- 385% Potential Profit! --

And Yet, Another Big Winner for the Week! !

by Ian Harvey

July 29, 2017

Share Share

AbbVie Inc (NYSE:ABBV)

Here is an overview of AbbVie Inc after reporting earnings. This options trade was recommended on Monday, July 24, 2017, with the company reporting on Thursday July 27; producing major potential profits within a very short period of executing the trade.

The Suggestion……from “Earnings Predictions for the Week Ahead”

Although Humira is doing well, the company is concerned about the product’s long-term prospects owing to the potential biosimilar competition; also a Humira patent litigation a concern. Viekira faces intense pricing and competitive pressure in the HCV market; and the weak performance continues this year with sales expected to decline to $1 billion in 2017.

The Trade……..

Option trade to consider: Buy the ABBV SEPT 15 2017 72.500 PUT at approximately $0.65.

The report………..

AbbVie reported adjusted earnings of $1.42 per share on $6.94 billion in revenue, compared to the analyst estimates of $$1.40 per share and $6.93 billion in revenue. In last year’s second quarter, the company posted $6.45 billion in revenue and adjusted earnings of $1.26 per share.

On a GAAP basis, AbbVie 2Q 17 earnings per share rose to $1.19 from 98 cents per share last year. Humira sales rose 13.7% to $4.7 billion, while Imbruvica sales rose 42.6% to $626 million. Viekira sales fell 41.4% to $488 million, while sales of Creon rose 15.6% to $381 million.

AbbVie confirmed its previously provided GAAP earnings outlook of $4.55 to $4.65 per share and adjusted earnings guidance of $5.44 to $5.54 per share.

After the AbbVie 2Q 17 earnings were released, the company’s stock was little changed in premarket trades as it hovered around $71.75 per share.

End Result……….

Shares of AbbVie touched a low on Friday of $69.38, on the back of cautious comments. AbbVie said it would be cautious with drug pricing, especially for Humira, the world's biggest selling drug, sending its shares down 2 percent, despite the drugmaker's quarterly profit narrowly beating estimates.

The Profit………

Within four days this trade produced a potential profit of 385%!


If you interested in being part of this profitable action just click here……

The results say it all!


”Success is simple. Do what's right, the right way, at the right time.”

Option Tip for your Success!
Options traders are not successful because they win.
Options traders win because they are successful.

Back to Stock Options Made Easy Home Page from AbbVie’s Options Trade -- 385% Potential Profit!

Search Stock Options
Made Easy

Enjoy Relaxed or Fast-Paced Trading? Choose your Membership Style...

Whether you prefer to take a laid-back approach to your trading,

or to charge ahead in your options trading,

 Stock Options Made Easy Armchair Trader and Cut-to-the-Chase Trader Memberships put everything you need to succeed at your fingertips for just  $39 or $79 per month.

Subscribe to our FREE
newsletter for all the latest options news!

Enter Your Email Address

Enter Your First Name